
Sign up to save your podcasts
Or


In the conclusion of a three-part series, BRG Managing Directors Christopher Goncalves and Robert Stoddard join the podcast to discuss how COVID-19 has played an important role in the recent record-low oil prices and the pandemic's effect on oil and natural gas. They also provide an idea on how this could lead to a new emphasis on green energy.
In the second of a special three-part series, BRG Managing Directors Brad Cornell and Peter Keller discuss how COVID-19 has affected the financial markets and clean energy efforts. They also talk about how investors steering away from the establishment of capital could affect the environmental sector.
In the first episode of a three-part series, BRG Managing Directors Roger Kaiser, Greg Russo, and Charles Cicchetti join the podcast to discuss potential ways to forecast the COVID-19 pandemic's effect on the economy and the energy sector. They weight in on factors companies and policymakers should consider in taking a first step towards normalcy.
In this episode, BRG managing directors John Kelliher, Paul Osborne, and Haywood Miller discuss how the Coronavirus (COVID-19) pandemic has affected the clinical and business models for healthcare providers and what tactics they are using to stabilize finances. They outline strategies hospitals should focus on once the United States enters the recovery stage of this crisis.
BRG Director Katie Norris speaks with Matt Turetzky of Norton Law Firm. Matt breaks down his experience in FCA matters within the healthcare industry and the challenges defendants may face in false claims. Katie and Matt also discuss whistle-blower claims and provide insights on how companies can litigate cases successfully.
BRG Managing Director Orlando Alvarez joins the podcast to speak about his work in healthcare strategy. In the ever-evolving healthcare industry, Strategic Agenda Management (SAM) can create a framework to measure the success of specific strategies. Orlando explains the benefits and functions of SAM along with his insights from two decades of healthcare experience.
BRG Principal Steven Parker, leader of the firm's Financial Investigations and Regulatory Compliance practice in the APAC region, joins us on this episode, which was recorded in anticipation of the Phase One trade deal with China. Steven discussed the evolving regulatory environment on mainland China and what it could mean for future joint ventures in the country. He also spoke about the increased focus on risk management for companies looking to invest in the region.
Dr. Shireen Meer, a director in BRG's Disputes & Investigations group, joins host Eddie Newland for a conversation on antitrust leniency. She discusses an article she recently coauthored on the topic, as well as other trends she has noticed in antitrust enforcement. Dr. Meer is an economist specializing in the application of economic analysis to litigation and consulting matters.
Phil speaks with Jill Kouri, chief marketing officer of real estate giant JLL, about her hands-on leadership style, improving gender parity in corporate America and … dirt bikes? They'll also discuss the changing role of the CMO and JLL's vision of itself for the coming years—specifically related to the company's new purpose statement.
From the publisher's feed